Skip to main content

Table 4 The effect of vildagliptin versus metformin on hepatic steatosis grading by ultrasound

From: The effect of vildagliptin versus metformin on hepatic steatosis in type 2 diabetic patients: a randomized controlled trial

 

Grade

Total

Vildagliptin

Metformin

P1

(n = 246)

(n = 117)

(n = 129)

n

%

n

%

n

%

Baseline

 

0

150

60.98

73

62.39

77

59.69

 
 

1

53

21.54

23

19.66

30

23.25

0.86

 

2

27

10.98

14

11.97

13

10.08

 
 

3

16

6.5

7

5.98

9

6.98

 

After six months

 

0

174

70.73

83

70.94

91

70.54

 
 

1

44

17.89

20

17.09

24

18.61

0.8

 

2

22

8.94

10

8.55

12

9.3

 
 

3

6

2.44

4

3.42

2

1.55

 

p

 

< 0.001

< 0.001

< 0.001

 
  1. p = comparison of baseline and 6-month follow-up results within the same group; p1 = comparison of baseline and 6-month follow-up results between the vildagliptin group and the metformin group
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us